AU2011284256B8 - Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases - Google Patents
Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases Download PDFInfo
- Publication number
- AU2011284256B8 AU2011284256B8 AU2011284256A AU2011284256A AU2011284256B8 AU 2011284256 B8 AU2011284256 B8 AU 2011284256B8 AU 2011284256 A AU2011284256 A AU 2011284256A AU 2011284256 A AU2011284256 A AU 2011284256A AU 2011284256 B8 AU2011284256 B8 AU 2011284256B8
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- methyl
- alkyl
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2140CH2010 | 2010-07-28 | ||
| IN2140/CHE/2010 | 2010-07-28 | ||
| IN525/CHE/2011 | 2011-02-23 | ||
| IN525CH2011 | 2011-02-23 | ||
| PCT/IN2011/000210 WO2012014218A1 (en) | 2010-07-28 | 2011-03-28 | Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| AU2011284256A1 AU2011284256A1 (en) | 2013-02-14 |
| AU2011284256B2 AU2011284256B2 (en) | 2014-05-29 |
| AU2011284256B8 true AU2011284256B8 (en) | 2014-11-13 |
| AU2011284256A8 AU2011284256A8 (en) | 2014-11-13 |
Family
ID=44247871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011284256A Ceased AU2011284256B8 (en) | 2010-07-28 | 2011-03-28 | Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20140187594A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2987488A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5957452B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103108634B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011284256B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2805245A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2565487T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE028725T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2598142T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012014218A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201300822B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3362053A4 (en) * | 2015-10-16 | 2019-04-17 | Hadasit Medical Research Services and Development Ltd. | TREATMENT OF NON-ALCOHOLIC FATTYLENE OR NON-ALCOHOLIC STEATOHEPATITIS WITH 6-MERCAPTOPURIN WITH DELAYED RELEASE |
| TWI762634B (zh) | 2017-05-05 | 2022-05-01 | 大陸商上海赫普化醫藥技術有限公司 | 胺基-芳基-苯甲醯胺化合物及其使用方法 |
| CN113750089B (zh) * | 2021-10-13 | 2023-09-19 | 南方医科大学南方医院 | 2-芳基-1,3二氢苯并咪唑衍生物在制备治疗慢性肝病的药物中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08109175A (ja) * | 1994-10-07 | 1996-04-30 | Torii Yakuhin Kk | チアゾリジン−2−オンエステル誘導体 |
| US7781464B2 (en) * | 2003-01-17 | 2010-08-24 | Bexel Pharmaceuticals, Inc. | Heterocyclic diphenyl ethers |
| US7521465B2 (en) * | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
| US6794401B2 (en) | 2003-01-17 | 2004-09-21 | Bexel Pharmaceuticals, Inc. | Amino acid phenoxy ethers |
| US7087576B2 (en) * | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
| JP2008533122A (ja) * | 2005-03-18 | 2008-08-21 | オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド | 新規なチロシン誘導体 |
| WO2006138475A2 (en) * | 2005-06-16 | 2006-12-28 | Jenrin Discovery | Mao-b inhibitors useful for treating obesity |
| WO2008106166A2 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors |
| JP2010520306A (ja) * | 2007-03-07 | 2010-06-10 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | エストロゲン関連受容体−αモジュレーターとしての置換フェノキシチアゾリジンジオン |
| WO2009030968A1 (en) * | 2007-09-05 | 2009-03-12 | Orchid Research Laboratories Limited | Mao a inhibitors with a diphenyl ether-substructure. |
| WO2009070781A1 (en) * | 2007-11-30 | 2009-06-04 | The Regents Of The University Of California | Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
-
2011
- 2011-03-28 US US13/809,604 patent/US20140187594A1/en not_active Abandoned
- 2011-03-28 EP EP15189194.2A patent/EP2987488A1/en not_active Withdrawn
- 2011-03-28 WO PCT/IN2011/000210 patent/WO2012014218A1/en not_active Ceased
- 2011-03-28 HU HUE11720594A patent/HUE028725T2/en unknown
- 2011-03-28 CN CN201180037004.1A patent/CN103108634B/zh not_active Expired - Fee Related
- 2011-03-28 EP EP11720594.8A patent/EP2598142B1/en not_active Not-in-force
- 2011-03-28 AU AU2011284256A patent/AU2011284256B8/en not_active Ceased
- 2011-03-28 PL PL11720594T patent/PL2598142T3/pl unknown
- 2011-03-28 JP JP2013521285A patent/JP5957452B2/ja not_active Expired - Fee Related
- 2011-03-28 ES ES11720594.8T patent/ES2565487T3/es active Active
- 2011-03-28 CA CA2805245A patent/CA2805245A1/en not_active Abandoned
-
2013
- 2013-01-31 ZA ZA2013/00822A patent/ZA201300822B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013532682A (ja) | 2013-08-19 |
| AU2011284256B2 (en) | 2014-05-29 |
| CN103108634A (zh) | 2013-05-15 |
| ZA201300822B (en) | 2014-04-30 |
| ES2565487T3 (es) | 2016-04-05 |
| US20140187594A1 (en) | 2014-07-03 |
| AU2011284256A1 (en) | 2013-02-14 |
| WO2012014218A1 (en) | 2012-02-02 |
| CA2805245A1 (en) | 2012-02-02 |
| EP2987488A1 (en) | 2016-02-24 |
| CN103108634B (zh) | 2015-08-12 |
| HUE028725T2 (en) | 2016-12-28 |
| AU2011284256A8 (en) | 2014-11-13 |
| JP5957452B2 (ja) | 2016-07-27 |
| EP2598142B1 (en) | 2015-12-16 |
| EP2598142A1 (en) | 2013-06-05 |
| PL2598142T3 (pl) | 2016-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2959842T3 (es) | Combinación de un agonista de PPAR con un agonista de FXR | |
| JP2010505783A (ja) | 非アルコール性脂肪肝炎の治療 | |
| US20200095210A1 (en) | Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases | |
| WO2012027548A1 (en) | Compounds and methods for prevention and treatment of alzheimer's and other diseases | |
| JP7040798B2 (ja) | 非アルコール性脂肪性肝疾患を処置するための5-[[4-[2-[5-(1-ヒドロキシエチル)ピリジン-2-イル]エトキシ]フェニル]メチル]-1,3-チアゾリジン-2,4-ジオン | |
| US20230130766A1 (en) | Mono and combination therapies with ulk1/2 inhibitors | |
| US20080027052A1 (en) | Methods for treating cystic kidney disease | |
| CN121335698A (zh) | 用于治疗肝脏病症或心脏代谢疾病的包含THR-β激动剂和GLP-1R激动剂的组合 | |
| KR20160108258A (ko) | 대사 질환의 예방 또는 치료용 조성물 | |
| AU2011284256B2 (en) | Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases | |
| US12310967B2 (en) | Compositions and methods of treatment for neurological disorders comprising motor neuron diseases | |
| KR102191405B1 (ko) | 간 질환 예방 또는 치료용 조성물 | |
| CN112105598B (zh) | 用于预防或治疗肥胖或代谢综合征的化合物和包含其的药学组合物 | |
| JP7682541B2 (ja) | 新規化合物およびこれを有効成分として含む呼吸器疾患の予防または治療用組成物 | |
| WO2004093910A1 (ja) | PPARδアゴニストによる脳神経変性疾患治療剤 | |
| CN111356764A (zh) | 降低血清胆固醇和pcsk9的组合物和方法 | |
| US12274703B2 (en) | Compositions and methods of treatment for neurological disorders comprising a dementia | |
| US20230104617A1 (en) | Compound for treating alzheimers disease | |
| KR101686872B1 (ko) | Tlr4에 lps와의 경쟁적 결합을 통한 항산화 및 항염증 활성을 갖는 신규 화합물 및 이의 의학적 용도 | |
| US20120010264A1 (en) | Novel medicament for treating cognitive impairment | |
| WO2017170860A1 (ja) | ヒートショックプロテイン47阻害剤 | |
| KR101889097B1 (ko) | 대사 질환의 예방 또는 치료용 조성물 | |
| CN113262218A (zh) | 异硫氰酸酯类化合物的用途 | |
| CN104211695A (zh) | 一组胺甲酰基苯磺酰类化合物的新用途 | |
| KR20250023492A (ko) | 플라보노이드 화합물, 및 섬유성 병태를 치료하기 위한 플라보노이드 화합물의 사용 방법 및 물질 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| TH | Corrigenda |
Free format text: IN VOL 28 , NO 21 , PAGE(S) 2877 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED, APPLICATION NO. 2011284256, UNDER INID (71) CORRECT THE APPLICANT NAME TO ORCHID CHEMICALS AND PHARMACEUTICALS LTD. Free format text: IN VOL 27 , NO 6 , PAGE(S) 859 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED, APPLICATION NO. 2011284256, UNDER INID (71) CORRECT THE APPLICANT NAME TO ORCHID CHEMICALS AND PHARMACEUTICALS LTD. |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |